Chief Financial Officer
Lyell Immunopharma
About this role
Lyell is a clinical-stage biopharmaceutical company focused on developing next-generation CAR T-cell therapies for solid and hematologic tumors. With a culture rooted in science, collaboration, and innovation, it aims to provide durable and effective immunotherapies for cancer patients.
Skills
Qualifications
About Lyell Immunopharma
lyell.comLyell is a fully integrated biopharmaceutical company developing next‑generation T‑cell reprogramming technologies to create durable CAR T‑cell therapies for hematologic malignancies and solid tumors. Their platform-driven approach spans discovery through clinical development, with active programs and trials such as the PiNACLE study for aggressive B‑cell non‑Hodgkin lymphoma and the recently acquired GCC‑targeted candidate LYL273. Lyell is patient‑focused, aiming to improve outcomes for cancers with significant unmet medical need.
Recent company news
Lyell Immunopharma (NASDAQ:LYEL) Now Covered by Citizens Jmp
4 days ago
Lyell Immunopharma: Fourth Quarter Financial Results Overview
1 day ago
Lyell Immunopharma closes $50M equity tranche, names new CFO
4 days ago
HC Wainwright & Co. Maintains Lyell Immunopharma (LYEL) Neutral Recommendation
5 days ago
Institutional investors are Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) biggest bettors and were rewarded after last week's US$72m market cap gain
Dec 17, 2025
About Lyell Immunopharma
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Lyell Immunopharma.
Salary
$150k – $250k
per year
More jobs at Lyell Immunopharma
Similar Jobs
Clinical Trial Manager
Immatics
Medical Science Liaison (Pacific Northwest)
Immatics
Manufacturing Associate II - Second Shift
Immatics
Cell Therapy MFG Intern (Manufacturing) Intern
Arcellx
Postdoctoral Researcher supporting Ivan Kotchetkov, embedded faculty in Minn Lab
Memorial Sloan Kettering Cancer Center
Scientist II - Smith Lab
DNA